Product
LKA651
1 clinical trial
1 indication
Indication
Diabetic Macular EdemaClinical trial
A Randomized, Active-controlled, Patient and Investigator-masked, Multiple Dose Proof-of-concept Study of Intravitreal LKA651 in Patients With Diabetic Macular EdemaStatus: Completed, Estimated PCD: 2022-06-17